Research Article | Open Access
The Angiogenic Potential of DPSCs and SCAPs in an In Vivo Model of Dental Pulp Regeneration
Adequate vascularization, a restricting factor for the survival of engineered tissues, is often promoted by the addition of stem cells or the appropriate angiogenic growth factors. In this study, human dental pulp stem cells (DPSCs) and stem cells from the apical papilla (SCAPs) were applied in an in vivo model of dental pulp regeneration in order to compare their regenerative potential and confirm their previously demonstrated paracrine angiogenic properties. 3D-printed hydroxyapatite scaffolds containing DPSCs and/or SCAPs were subcutaneously transplanted into immunocompromised mice. After twelve weeks, histological and ultrastructural analysis demonstrated the regeneration of vascularized pulp-like tissue as well as mineralized tissue formation in all stem cell constructs. Despite the secretion of vascular endothelial growth factor in vitro, the stem cell constructs did not display a higher vascularization rate in comparison to control conditions. Similar results were found after eight weeks, which suggests both osteogenic/odontogenic differentiation of the transplanted stem cells and the promotion of angiogenesis in this particular setting. In conclusion, this is the first study to demonstrate the successful formation of vascularized pulp-like tissue in 3D-printed scaffolds containing dental stem cells, emphasizing the promising role of this approach in dental tissue engineering.
Sufficient vascular supply is a restricting factor for the survival of engineered and transplanted tissues. Within the field of regenerative dentistry and the treatment of necrotic, immature, permanent teeth in particular, the establishment of adequate tissue vascularization remains a challenge . The currently applied regenerative endodontic procedures (REP) comprise the induction of a blood clot, causing both the release of sequestered growth factors and the attraction of endogenous (stem) cells, such as stem cells from the apical papilla (SCAPs) [2, 3]. However, in addition to the questionable histological nature of the regenerated tissues [4, 5], adequate pulp tissue revascularization is an often recurring concern in cell homing-based approaches given the limited vascular access through the apical foramen .
Although a number of studies suggest a positive correlation between pulp revascularization and an increasing size of the root apex [6–8], the use of stem cell-based approaches has demonstrated the successful regeneration of vascularized dental pulp-like tissue in canine teeth with a small apical opening. Transplantation of dental pulp stem cells (DPSCs) even led to a more distinct volume of regenerated dental tissue with a higher capillary density in comparison to a growth factor-based approach . These data are in accordance with the previously demonstrated angiogenic properties of dental stem cells (DSCs) in vitro and in vivo. Recent work from our group and others reported that both DPSCs and SCAPs express a wide range of regulatory angiogenic proteins, including but not limited to vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), angiopoietin-1, matrix metalloproteinases, endostatin, thrombospondin-1, and insulin-like growth factor-binding protein-3 [10–17]. In addition to the secretion of the aforementioned factors, numerous studies have reported the paracrine influence of DPSCs and SCAPs on endothelial proliferation, migration, and tube formation both in vitro and in vivo, for example, in a rat model of myocardial infarction [10, 12, 14, 18–22].
With regard to the application of (dental) stem cells in dental pulp regeneration, the ectopic root transplantation model, that is, the transplantation of emptied human root canals, is considered to be a widely applied proof-of-principle model . Notwithstanding the elaborate application of this animal model as well as the fact that it takes into consideration the limited dental vascular supply, the size and shape of human root canals are very prone to variability [19, 23–25]. Three-dimensional (3D) printing or additive manufacturing, that is, the inkjet-based production of 3D structures by printing liquid binders onto loose powders, provides an alternative means to create custom-made, inorganic scaffolds with a controllable chemistry and porosity. As 3D printing allows the use of a wide variety of biomaterials, such as bioactive glasses, polylactic acid (PLA), polyethylene glycol (PEG), or hydroxyapatite (HA), it has a great clinical potential in the field of organ and tissue replacement [26, 27]. Mannoor et al., for example, reconstructed a bionic ear through 3D printing of a cell-seeded hydrogel matrix . Khalyfa and coworkers reported the production of craniofacial segments based on calcium phosphate powders . Given the broad availability of biomaterials as well as the ability to produce scaffolds with a custom-made design according to the patient’s needs, 3D printing also shows great promise in the field of regenerative dentistry [30, 31]. Chiu et al., for example, recently reported the successful osteogenic differentiation of DPSCs in cultured 3D-printed mineral trioxide aggregate/polycaprolactone scaffolds . Similar results were found by Louvrier and coworkers, indicating the in vitro odontoblastic differentiation potential of DPSCs in a 3D-printed polycaprolactone-based scaffold . With regard to the in vivo potential of 3D-printed scaffolds, Wei et al. described the formation of a bio-root complex after in situ transplantation of HA/tricalcium phosphate scaffolds containing DPSCs and periodontal ligament stem cells in pigs . Furthermore, recent studies also demonstrated the creation of vascular templates, facilitating the perfusion of tissue constructs and thus ameliorating cell viability [35, 36].
This study aims to investigate the regenerative potential of DPSCs and SCAPs and their ability to sustain their paracrine angiogenic potential in an ectopic transplantation model of dental pulp regeneration. Since the biocompatibility and effectiveness of HA has already been demonstrated in vivo [34, 37–39], 3D-printed, conically shaped HA scaffolds in order to mimic the tooth’s morphology and to minimize scaffold-related variability. To our knowledge, this is one of the first studies that combines DSCs with the aforementioned scaffolds in a model for dental pulp tissue engineering. DPSCs and SCAPs are supported by a commercially available, self-assembling peptide hydrogel, which is proven to maintain DSC viability both in vitro and in vivo [19, 24, 40]. Constructs are characterized by both scanning electron microscopy and secretion of VEGF. After twelve and eight weeks of transplantation into immunocompromised mice, tissue content and vascularization are assessed at the histological and ultrastructural level. Given the previously demonstrated angiogenic properties of DPSCs and SCAPs as well as their potential to regenerate dental tissues, we expect to observe the successful regeneration of a strongly vascularized dentin/pulp-like complex after transplantation of 3D-printed HA scaffolds containing DSCs.
2. Materials and Methods
2.1. Cell Culture
Dental tissues were acquired with informed consent from patients (15–20 years of age, male and female) undergoing extraction of third molars for therapeutic or orthodontic reasons at Ziekenhuis Maas en Kempen, Bree and Ziekenhuis Oost-Limburg, Genk, Belgium. Written informed consent of underaged patients was obtained through their guardians, as approved by the medical ethical committee of Hasselt University, Belgium (protocol 13/0104U). The apical papilla was immediately resected from the tooth after extraction, while the pulp tissue was obtained with forceps after mechanically fracturing the disinfected tooth with surgical chisels. Dental tissues were rinsed and transported at 37°C in Minimal Essential Medium Eagle, alpha modification (αMEM, Sigma-Aldrich, St. Louis, USA) supplemented with 2 mM L-glutamine (Sigma-Aldrich), 100 U/ml penicillin, 100 μg/ml streptomycin (Sigma-Aldrich), and 10% fetal bovine serum (FBS, Gibco, ThermoFisher Scientific, Waltham, USA). This medium is further referred to as standard DSC culture medium. DPSCs and SCAPs were isolated according to the explant method as described previously by our group . Briefly, dental tissues were cut into 1-2 mm3 fragments, which were cultured in standard DSC culture medium for 10–14 days to allow cellular outgrowth. When 80% confluency was reached, DSCs were retrieved from the culture plates by means of 0.05% trypsin/EDTA and subcultured for further experiments. All DSC cultures were tested for the expression of the following (stem) cell markers at protein level by means of flow cytometry as described previously : CD31, CD34, CD45, CD73, CD90, and CD105. In order to minimize patient-related variability and the amount of animals required for the ectopic transplantation model, DPSCs and SCAPs (passage 1) of three different donors were pooled and maintained in standard DSC culture medium. The pooled stem cells were cryopreserved in liquid nitrogen for further experiments. All experiments were performed with thawed passage 2-3 DPSCs and SCAPs.
2.2. Scaffold Production and Characterization
In order to mimic the size and shape of a tooth root, 3D-printed, conically shaped HA constructs with a standardized length of 4.9 mm and a representative apical opening of 1.7 mm were used in this study (Figure 1) [6–8]. All scaffolds were custom-made by Sirris (Seraing, Belgium). Briefly, constructs were created in a layer-by-layer fashion through additive manufacturing using a paste containing hydroxyapatite/tricalcium phosphate (HA/TCP) powder, resins, and an ultraviolet (UV) photoinitiator. Polymerization of each layer was achieved by means of UV light, after which the scaffolds were cleaned. All scaffolds were thermally treated in order to remove potential residues of organic material. Finally, the scaffolds were sintered to increase their density. Scanning electron microscopy (SEM) was performed to assess the surface characteristics of the constructs.
2.3. Assessment of Vascular Endothelial Growth Factor Secretion
In order to evaluate the survival and secretion of VEGF by DSCs within the scaffolds and the supporting hydrogel, an enzyme-linked immunosorbent assay (ELISA) against VEGF (Raybiotech, Norcross, GA, USA) was performed on conditioned medium of constructs containing 50,000 DPSCs according to the manufacturer’s instructions. Briefly, scaffolds were injected with a 1 : 1 solution of phosphate-buffered saline (PBS) and pooled DPSCs in 0.2% Puramatrix™ peptide hydrogel (Corning Life Sciences, Tewksbury, MA, USA), after which they were maintained in standard DSC culture medium during four weeks. After 14 days and 28 days of culturing, conditioned medium was obtained by incubating the constructs for 48 h with standard DSC culture medium containing 0.1% FBS.
2.4. Ectopic Transplantation Model
Scaffolds containing either 0.2% hydrogel (Puramatrix, negative control condition) or a 0.2% hydrogel suspension combined with 25,000 DPSCs and 25,000 SCAPs or a 1 : 1 mixture of DPSCs and SCAPs were subcutaneously transplanted into the dorsum of 8-week-old, female, severe combined immunodeficient (SCID) hairless outbred (SHO™) mice (SHO-PrkdcscidHrhr, Charles River, Wilmington, MA, USA). Following eight (, six animals per group) or twelve (, eight animals per group) weeks of transplantation, the constructs were resected from the mice and processed for histological stainings and ultrastructural analysis as described below. Before sectioning, macroscopic signs of blood vessel growth were assessed by means of a stereomicroscope (Wild M3Z Stereomicroscope, Heerbrugg, Switzerland) equipped with a Nikon digital net camera DN100 (Nikon Co., Shinjuku, Tokyo, Japan). This study was approved by the Ethical Committee on Animal Experiments (ECAE) of Hasselt University, Belgium (protocol 201332V1).
2.5. Histological Stainings
Resected constructs (, eight weeks, and , twelve weeks) were fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich, St. Louis, USA) for 48 h at room temperature. Following fixation, the base of the conically shaped scaffolds was removed with a surgical saw, to allow complete impregnation of the formed tissue in paraffin. The resulting cylinders were dehydrated in graded alcohol and embedded in paraffin (Paraplast Plus, Surgipath, Leica Biosystems, Wetzlar, Germany). Paraffin-embedded constructs were decalcified (decalcifying solution, Thermo Scientific™, Richard-Allan Scientific, Waltham, MA, USA) for 24 h at room temperature, after which the paraffin was melted again to allow better impregnation of the decalcified constructs. Afterwards, a hematoxylin and eosin (H&E) staining as well as a Masson’s trichrome staining was performed on serial tissue sections (7 μm). Sections were scanned with a Mirax digital slide scanner (Carl Zeiss Vision, Aalen, Germany), and the amount of blood vessels was determined for each tissue section by counting the blood vessels in the entire construct by means of Panoramic Viewer software (3DHISTECH Ltd., Budapest, Hungary). In order to determine the percentage of newly formed tissue, the ratio of the measured surface of newly formed tissue (mm2) and the total inner surface area (mm2) of each tissue section was calculated. The vascularization rate was defined by the ratio of the amount of blood vessels in each tissue section and the measured surface of newly formed tissue (mm2).
2.6. Ultrastructural Analysis
Resected constructs (, eight weeks and , twelve weeks) were fixed with 2% glutaraldehyde in 0.05 M sodium cacodylate buffer (pH 7.3) at 4°C. Following fixation, the base of the conical scaffolds was removed with a surgical saw, to allow better postfixation. The resulting cylinders were treated with 2% osmium tetroxide in 0.05 M sodium cacodylate buffer (pH 7.3) for 1 h at 4°C. The constructs were stained with 2% uranyl acetate in 10% acetone for 20 min, after which they were dehydrated with ascending concentrations of acetone. The dehydrated samples were impregnated overnight in 1 : 1 mixture of acetone and araldite epoxy resin at room temperature. Following impregnation, the samples were embedded in araldite epoxy resin at 60°C. Araldite-embedded constructs were decalcified (decalcifying solution, Thermo Scientific) for 24 h, after which they were refilled with araldite and cut into semithin (0.5 μm) and thin sections (70 nm) with a Leica EM UC6 microtome. Semithin sections were stained with thionine methylene blue, and representative pictures were taken with a Nikon Eclipse 80i microscope equipped with a DS-5 M digital camera. Thin sections were transferred to 0.7% formvar-coated copper grids (Aurion, Wageningen, The Netherlands) and contrasted with 0.5% uranyl acetate and a stabilized solution of lead citrate by means of a Leica EM AC20. Transmission electron microscopy (TEM) was performed with a Philips EM208 S electron microscope (Philips, Eindhoven, The Netherlands). Representative digital images were obtained with a Morada Soft Imaging System camera and the corresponding ITEM-FEI software (Olympus SIS, Münster, Germany).
2.7. Exclusion Criteria and Statistics
Scaffolds that were compromised during tissue processing were excluded from the study (, twelve weeks). Constructs containing less than 10% newly formed tissue were considered to be empty and excluded from further characterization and parameter calculation (, eight and twelve weeks). Statistical analysis was performed using GraphPad Prism 5 Software (GraphPad Software, La Jolla, CA, USA). Data distribution was assessed by means of a D’Agostino & Pearson normality test. As in each group, data distribution was considered to be nonparametric. Data were compared with a Kruskall-Wallis test combined with a Dunn’s posthoc test. Differences were considered to be statistically significant at values ≤ 0.05. All data were expressed as mean ± standard deviation (SD). value < 0.05; value < 0.01; and value < 0.001.
3.1. Characterization of Dental Stem Cells
Flow cytometry analysis indicated the expression of typical stem cell markers by DSCs (Figure 2). Both DPSCs (Figure 2(a)) and SCAPs (Figure 2(b)) showed a pronounced expression of CD73, CD90, and CD105, while they were negative for CD31, CD34, and CD45.
3.2. Characterization of Stem Cell Constructs
SEM analysis was performed in order to obtain a detailed view of both the scaffolds’ structure and surface characteristics (Figure 3). In addition to distinct layers of deposited HA (arrow, Figure 3(b)), a pseudoporous surface was also visible (Figure 3(c)). However, in-depth analysis of the constructs indicated rather dense HA layers, without clearly distinguishable pores (Figure 3(d)).
The angiogenic properties of DPSCs within the scaffolds were evaluated by means of an ELISA against VEGF. After 14 days of culturing, the conditioned medium of the constructs contained a substantial amount of VEGF. VEGF secretion increased further after 28 days of culturing (Figure 4).
3.3. Evaluation of Vascularized Tissue Regeneration after Twelve Weeks of Transplantation
After 12 weeks of transplantation, all constructs were resected and assessed for macroscopic signs of blood vessel ingrowth (Figure 5). Although blood vessel ingrowth was present in approximately all the resected constructs, the color of the tissue as well as the distinct presence of blood vessels differed not only between the experimental groups (negative control condition (Figures 5(a) and 5(b)); DPSCs (Figures 5(c) and 5(d)); SCAPs (Figures 5(e) and 5(f)); and DPSCs + SCAPs (Figures 5(g) and 5(h))) but also within the samples of the same experimental condition.
With regard to the histological characterization of the 3D constructs, Masson’s trichrome staining indicated the formation of a vascularized pulp-like tissue in all the constructs containing stem cells (Figures 6(c), 6(d), and 6(e)). Although the newly formed tissue was structurally similar to human dental pulp tissue (Figures 6(a) and 6(f)), it contained notably less collagen. The negative control constructs (0.2% Puramatrix without cells), on the other hand, also comprised vascularized, fibrous tissue, albeit with a different organizational structure (Figures 6(b) and 6(g)). While the outer tissue border of the stem cell constructs showed strongly organized, concentric layers of collagen and, in certain cases, mineralized tissue formation (Figures 6(h), 6(i), and 6(j), arrows), only two out of four negative control constructs showed loosely arranged, concentric layers of collagen (Figure 6(g)).
Microscopical analysis of H&E-stained tissue sections (Figure 7(i)) demonstrated a significantly lower percentage of newly formed tissue within the negative control condition (0.2% Puramatrix without cells) in comparison to the scaffolds containing stem cells, in particular SCAPs. In terms of blood vessel content, the presence of small as well as larger (sometimes ruptured) blood vessels was demonstrated in all experimental conditions (Figures 7(a), 7(b), 7(c), 7(d), 7(e), 7(f), 7(g), and 7(h)). While containing a significantly lower amount of tissue (Figure 7(i)), the negative control condition in particular seemed to contain a significantly higher amount of blood vessels (Figure 7(j)). Similar observations were made when calculating the amount of blood vessels per mm2 of newly formed tissue (Figure 7(k)).
3.4. Ultrastructural Analysis of 3D Constructs after Twelve Weeks of Transplantation
Microscopical analysis of thionine methylene blue-stained semithin tissue sections confirmed the aforementioned histological characterization of the 3D constructs, indicating the presence of differentially organized connective tissue in all of the samples (Figures 8(a), 8(b), 8(c), and 8(d)). Distinct patches of mineralized tissue were present in constructs containing DPSC + SCAPs (Figure 8(d)) and DPSCs (Figures 8(f), 8(g), and 8(h)), respectively. The cells within the constructs were mostly aligned against the mineralized tissue (Figure 8(f)), although in certain regions cellular protrusions were visible within the tissue (Figures 8(g) and 8(h), arrow). Nerve fibers were also detected in the tissue surrounding the outer rim of all the constructs (Figure 8(e)). At the ultrastructural level, mature blood vessels of variable shapes and sizes were observed in all vesicles (Figure 8(j), arrow); all samples showed signs of active collagen secretion (Figures 8(k) and 8(l), Co). Tissue deposits containing HA needles and collagen in various stages of mineralization were clearly present in the constructs containing stem cells (Figure 8(l), De). This was not the case in the negative control sample (0.2% Puramatrix without cells), which only contained patches of collagen secretion (Figure 8(k)).
Both the significantly lower amount of blood vessels and the lower vascularization rate in the stem cell constructs in comparison to those of the negative control condition after twelve weeks of transplantation (Figure 7) suggest that the time frame of transplantation might play a role in the attraction of endogenous cells and/or vascular supply in the negative control constructs. Since angiogenesis is a self-limiting biological process, the angiogenic potential of the stem cells may have reached a plateau phase during these twelve weeks and thereby stimulated the inherent hard tissue-forming capacity of DPSCs and SCAPs, as demonstrated by the patches of mineralized tissue formation in all stem cell constructs (Figure 8). Therefore, the experimental set-up was repeated with similar conditions for a shortened period of time, that is, eight weeks.
3.5. Histological and Ultrastructural Characterization of 3D Constructs after Eight Weeks of Transplantation
After eight weeks of transplantation, all constructs were resected and assessed for macroscopic signs of bloods vessel ingrowth (Figure 9, arrows). Similar to the 12-week transplantation period, blood vessel in-growth could be observed in most of the resected constructs, with notable differences between experimental groups and within constructs of the same experimental condition with regard to the color of the tissue and the amount of visible blood vessels.
In terms of histological characterization, both the H&E-stained and Masson’s trichrome-stained tissue sections were similar to the ones of the 12-week transplantation period (Figures 10(a), 10(b), 10(c), 10(d), 10(e), 10(f), 10(g), 10(h), 10(i), 10(j), 10(k), and 10(l)). While the stem cell constructs contained vascularized pulp-like tissue structurally similar to human dental pulp tissue (Figures 10(b), 10(c), 10(d), 10(f), 10(g), and 10(h)), negative control constructs (0.2% Puramatrix without cells) comprised vascularized, fibrous tissue with a notably different structural organization (Figures 10(a) and 10(e)). The outer border of the stem cell constructs showed either strongly organized, concentric layers of collagen (SCAPs, Figure 10(k)) or mineralized tissue formation (DPSCs or DPSCs + SCAPs, Figures 10(j) and 10(l), arrows). Negative control constructs comprised very loosely arranged collagen fibers (Figure 10(i)), with the exception of one sample which seemed to contain substantial amount of calcified tissue (data not shown). With regard to the percentage of newly formed tissue within the constructs, microscopical analysis demonstrated a trend similar to the 12-week transplantation period, although no statistically significant differences were detected between the experimental conditions (Figures 10(a), 10(b), 10(c), 10(d), and 10(q)). In contrast to the 12-week transplantation period, analysis of the blood vessel content showed a seemingly, but not significantly, higher amount of blood vessels in the constructs containing DPSCs (Figure 10(r)). However, calculation of the vascularization rate demonstrated a trend towards higher amount of blood vessels per mm2 of newly formed tissue in the negative control condition, albeit with a considerable variability between the different samples (Figure 10(s)).
Regarding the ultrastructural analysis, thionine methylene blue-stained semithin tissue sections pointed out that only two (DPSCs and DPSCs + SCAPs) out of four processed samples showed signs of new tissue formation. Either active collagen secretion or distinct patches of mineralized tissue were present in the vascularized tissue (Figures 10(m) and 10(n)) or mineralized tissue with cellular protrusions (Figure 10(o), arrow). Nerve fibers were only detected in the tissue surrounding the outer border of two out of four samples (Figure 10(p)).
Within the field of regenerative endodontic procedures and dental tissue engineering, the limited vascular supply of the tooth due to the size of the root apex is an often recurring concern, in particular in the treatment of necrotic, immature permanent teeth [1, 6, 10]. However, Takeuchi and coworkers reported the successful regeneration of highly vascularized dental pulp tissue after transplantation of DPSCs in root canals with an apical opening of 0.7 mm . Our group previously demonstrated the angiogenic properties of DPSCs and SCAPs in vitro as well as in an in vivo-like setting . In order to investigate whether these stem cells sustain their angiogenic potential in a standardized, in vivo setting, an ectopic transplantation model of dental pulp regeneration was performed in immunocompromised mice. More specifically, conically shaped, 3D-printed scaffolds containing a self-assembling peptide hydrogel (Puramatrix) and/or DPSCs, SCAPs, or DPSCs + SCAPs were subcutaneously transplanted in SCID mice for eight or twelve weeks.
After a transplantation period of twelve weeks, histological analysis demonstrated the formation of vascularized pulp-like tissue in all constructs containing stem cells. Although structurally similar to human dental pulp tissue, the newly formed tissue displayed a notably lower collagen content. Similar findings were reported previously by Rosa et al. and others, indicating a more densely organized extracellular matrix in human dental pulps [24, 25]. This enhanced matrix formation was also observed after transplantation of human root canals comprising cocultures of DPSCs and endothelial cells . Despite being contained within multiple layers of hydroxyapatite, DPSCs were still able to secrete substantial amounts of VEGF in vitro, as demonstrated by ELISA. In vivo, however, stem cell constructs did not display a larger amount of blood vessels in comparison to the negative control condition after twelve weeks of transplantation. While the latter comprised on average 20% less tissue, the average number of blood vessels per mm2 of newly formed tissue was significantly higher, in particular in comparison to that of the condition containing DPSCs + SCAPs. In contrast, Dissanayaka et al. reported the complete absence of vascularized pulp-like tissue in their control, that is, sealed human root canals containing Puramatrix, after four weeks of transplantation . Rosa and coworkers, on the other hand, observed a minimal amount of poorly organized tissue in open human root canals containing the same self-assembling peptide hydrogel devoid of stem cells after 35 days of transplantation .
As mentioned earlier, the applied 12-week transplantation period in this study might have played a role in the attraction of endogenous cells and the vascularization of the negative control constructs. Furthermore, due to the relatively long time period, the angiogenic potential of DPSCs and SCAPs could have stagnated and caused the stimulation of the inherent odontogenic and/or osteogenic differentiation capacity of the stem cells, as demonstrated by the distinct regions of mineralized tissue formation within the stem cell constructs. Therefore, an intermediate transplantation period of eight weeks was chosen to repeat the experimental set-up.
Histological and ultrastructural characterization of these constructs, however, confirmed the presence of vascularized pulp-like tissue with patches of mineralized tissue formation in the stem cell constructs, similar to the tissue formed after twelve weeks of transplantation. Although DPSC constructs did contain a seemingly higher amount of blood vessels, a trend towards a lower vascularization rate within the stem cell constructs was observed after calculation of the number of blood vessels per mm2 of newly formed tissue. Next to the determining role of the transplantation period, these results suggest that the intrinsic properties of the scaffold itself could have influenced the behavior of the transplanted cells substantially. Hydroxyapatite, for example, displays a distinct osteoinductive capacity and has been shown to promote the osteogenic differentiation of mesenchymal stem cells [42, 43]. The absence of soluble dentin matrix components, on the other hand, might explain the lower vascularization rate of the stem cell constructs as these proteins are expected to have additional proangiogenic effects together with the transplanted DPSCs and SCAPs . Angiogenic growth factors such as VEGF and bFGF can also stimulate the hard tissue-forming capacity of mesenchymal stem cells [45–48]. Lentiviral transfection of VEGF, for example, resulted in the successful odontogenic differentiation of human DPSCs in vitro . An autoregulatory mechanism reduces the proangiogenic potential of the differentiated cells as stated by Hoch et al., who demonstrated a significant reduction of both VEGF mRNA levels and angiogenesis-promoting effects in vitro of osteogenically differentiated mesenchymal stem cells . Another important aspect one has to keep in mind in tissue engineering and transplantation studies is the number of cells related to the size of the scaffold, as a high cell seeding density can be a defining factor for the differentiation potential of mesenchymal stem cells in general [50, 51].
In addition to being strongly vascularized, dental pulp is also a highly innervated tissue. However, after eight as well as twelve weeks of transplantation, nerve fibers were only present in the tissue closely surrounding the constructs. Given the fact that previously published data only concerned newly formed tissue within the transplanted constructs, it is difficult to compare these results. However, the presence and ingrowth of nerve fibers in vascularized pulp-like tissue has been mentioned by Iohara and co-workers, following a two-week transplantation period of a DPSC subpopulation in pulpectomized dog teeth [52, 53]. As these nerve fibers originated from apical tissue, these results indicate that the attraction or regeneration of nerve fibers requires specific cues from the oral environment, which are seemingly absent in the subcutaneous environment of the ectopic root transplantation model.
Taken together, these data confirm the ability of DPSCs and SCAPs to regenerate vascularized pulp-like tissue in 3D-printed HA scaffolds. Although DPSCs and SCAPs were able to sustain their angiogenic potential to a certain degree in vivo, the microenvironment at the time of transplantation also promoted the inherent hard tissue-forming potential of the stem cells, which potentially diminished the induction of angiogenesis.
Despite their previously demonstrated angiogenic potential in vitro, constructs containing DPSCs and/or SCAPs did not display a higher vascularization rate in comparison to control constructs, which was probably due to odontogenic and/or osteogenic differentiation of the stem cells. Given its determining role in cellular differentiation and paracrine properties, a stable microenvironment has to be recreated at the time of regeneration. More specifically, in order to create a balance between the maximum angiogenic potential of DPSCS and their inherent hard tissue-forming capacity, the right scaffold has to be combined with the right (amount of) stem cells within the most optimal time frame to establish ideal circumstances for regeneration. Nevertheless, this study shows the successful formation of vascularized dentin/pulp-like tissue after transplantation of 3D-printed hydroxyapatite scaffolds containing DPSCs and/or SCAPs. This approach opens up new perspectives for the application of 3D-printed stem cell constructs in the field of dental tissue engineering.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
This research was supported by a research grant of the Research Foundation-Flanders (FWO, 1506013N). Petra Hilkens and Annelies Bronckaers are postdoctoral research fellows of the FWO. The authors would like to thank Raphael Goffard and Bruno Verlee for their indispensable help with the design and production of the 3D-printed scaffolds.
- P. Hilkens, N. Meschi, P. Lambrechts, A. Bronckaers, and I. Lambrichts, “Dental stem cells in pulp regeneration: near future or long road ahead?” Stem Cells and Development, vol. 24, no. 14, pp. 1610–1622, 2015.
- K. M. Hargreaves, A. Diogenes, and F. B. Teixeira, “Treatment options: biological basis of regenerative endodontic procedures,” Journal of Endodontia, vol. 39, Supplement 3, pp. S30–S43, 2013.
- B. Kahler, G. Rossi-Fedele, N. Chugal, and L. M. Lin, “An evidence-based review of the efficacy of treatment approaches for immature permanent teeth with pulp necrosis,” Journal of Endodontia, vol. 43, no. 7, pp. 1052–1057, 2017.
- A. Diogenes, N. B. Ruparel, Y. Shiloah, and K. M. Hargreaves, “Regenerative endodontics: a way forward,” Journal of the American Dental Association (1939), vol. 147, no. 5, pp. 372–380, 2016.
- M. Altaii, L. Richards, and G. Rossi-Fedele, “Histological assessment of regenerative endodontic treatment in animal studies with different scaffolds: a systematic review,” Dental Traumatology, vol. 33, no. 4, pp. 235–244, 2017.
- G. T. Huang, M. Al-Habib, and P. Gauthier, “Challenges of stem cell-based pulp and dentin regeneration: a clinical perspective,” Endodontic Topics, vol. 28, no. 1, pp. 51–60, 2013.
- J. O. Andreasen, M. K. Borum, H. L. Jacobsen, and F. M. Andreasen, “Replantation of 400 avulsed permanent incisors. 2. Factors related to pulpal healing,” Endodontics & Dental Traumatology, vol. 11, no. 2, pp. 59–68, 1995.
- M. Kling, M. Cvek, and I. Mejare, “Rate and predictability of pulp revascularization in therapeutically reimplanted permanent incisors,” Endodontics & Dental Traumatology, vol. 2, no. 3, pp. 83–89, 1986.
- N. Takeuchi, Y. Hayashi, M. Murakami et al., “Similar in vitro effects and pulp regeneration in ectopic tooth transplantation by basic fibroblast growth factor and granulocyte-colony stimulating factor,” Oral Diseases, vol. 21, no. 1, pp. 113–122, 2015.
- P. Hilkens, Y. Fanton, W. Martens et al., “Pro-angiogenic impact of dental stem cells in vitro and in vivo,” Stem Cell Research, vol. 12, no. 3, pp. 778–790, 2014.
- A. Bakopoulou, A. Kritis, D. Andreadis et al., “Angiogenic potential and secretome of human apical papilla mesenchymal stem cells in various stress microenvironments,” Stem Cells and Development, vol. 24, no. 21, pp. 2496–2512, 2015.
- A. Bronckaers, P. Hilkens, Y. Fanton et al., “Angiogenic properties of human dental pulp stem cells,” PLoS One, vol. 8, no. 8, article e71104, 2013.
- M. Nakashima, K. Iohara, and M. Sugiyama, “Human dental pulp stem cells with highly angiogenic and neurogenic potential for possible use in pulp regeneration,” Cytokine & Growth Factor Reviews, vol. 20, no. 5-6, pp. 435–440, 2009.
- L. Tran-Hung, S. Mathieu, and I. About, “Role of human pulp fibroblasts in angiogenesis,” Journal of Dental Research, vol. 85, no. 9, pp. 819–823, 2006.
- J. Vanacker, A. Viswanath, P. De Berdt et al., “Hypoxia modulates the differentiation potential of stem cells of the apical papilla,” Journal of Endodontia, vol. 40, no. 9, pp. 1410–1418, 2014.
- S. Yu, Y. Zhao, Y. Ma, and L. Ge, “Profiling the secretome of human stem cells from dental apical papilla,” Stem Cells and Development, vol. 25, no. 6, pp. 499–508, 2016.
- J. Ratajczak, A. Bronckaers, Y. Dillen et al., “The neurovascular properties of dental stem cells and their importance in dental tissue engineering,” Stem Cells International, vol. 2016, Article ID 9762871, 17 pages, 2016.
- A. M. Aranha, Z. Zhang, K. G. Neiva, C. A. Costa, J. Hebling, and J. E. Nör, “Hypoxia enhances the angiogenic potential of human dental pulp cells,” Journal of Endodontia, vol. 36, no. 10, pp. 1633–1637, 2010.
- W. L. Dissanayaka, K. M. Hargreaves, L. Jin, L. P. Samaranayake, and C. Zhang, “The interplay of dental pulp stem cells and endothelial cells in an injectable peptide hydrogel on angiogenesis and pulp regeneration in vivo,” Tissue Engineering Part A, vol. 21, no. 3-4, pp. 550–563, 2015.
- K. Iohara, L. Zheng, H. Wake et al., “A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp,” Stem Cells, vol. 26, no. 9, pp. 2408–2418, 2008.
- C. Yuan, P. Wang, L. Zhu et al., “Coculture of stem cells from apical papilla and human umbilical vein endothelial cell under hypoxia increases the formation of three-dimensional vessel-like structures in vitro,” Tissue Engineering Part A, vol. 21, no. 5-6, pp. 1163–1172, 2015.
- C. Gandia, A. Armiñan, J. M. García-Verdugo et al., “Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction,” Stem Cells, vol. 26, no. 3, pp. 638–645, 2008.
- G. T. Huang, T. Yamaza, L. D. Shea et al., “Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model,” Tissue Engineering Part A, vol. 16, no. 2, pp. 605–615, 2010.
- V. Rosa, Z. Zhang, R. H. Grande, and J. E. Nör, “Dental pulp tissue engineering in full-length human root canals,” Journal of Dental Research, vol. 92, no. 11, pp. 970–975, 2013.
- J. W. Yang, Y. F. Zhang, C. Y. Wan et al., “Autophagy in SDF-1alpha-mediated DPSC migration and pulp regeneration,” Biomaterials, vol. 44, pp. 11–23, 2015.
- S. Bose, S. Tarafder, and A. Bandyopadhyay, “Effect of chemistry on osteogenesis and angiogenesis towards bone tissue engineering using 3D printed scaffolds,” Annals of Biomedical Engineering, vol. 45, no. 1, pp. 261–272, 2017.
- R. Partridge, N. Conlisk, and J. A. Davies, “In-lab three-dimensional printing: an inexpensive tool for experimentation and visualization for the field of organogenesis,” Organogenesis, vol. 8, no. 1, pp. 22–27, 2012.
- M. S. Mannoor, Z. Jiang, T. James et al., “3D printed bionic ears,” Nano Letters, vol. 13, no. 6, pp. 2634–2639, 2013.
- A. Khalyfa, S. Vogt, J. Weisser et al., “Development of a new calcium phosphate powder-binder system for the 3D printing of patient specific implants,” Journal of Materials Science: Materials in Medicine, vol. 18, no. 5, pp. 909–916, 2007.
- C. Rombouts, T. Giraud, C. Jeanneau, and I. About, “Pulp vascularization during tooth development, regeneration, and therapy,” Journal of Dental Research, vol. 96, no. 2, pp. 137–144, 2017.
- R. van Noort, “The future of dental devices is digital,” Dental Materials, vol. 28, no. 1, pp. 3–12, 2012.
- Y. C. Chiu, H. Y. Fang, T. T. Hsu, C. Y. Lin, and M. Y. Shie, “The characteristics of mineral trioxide aggregate/polycaprolactone 3-dimensional scaffold with osteogenesis properties for tissue regeneration,” Journal of Endodontia, vol. 43, no. 6, pp. 923–929, 2017.
- A. Louvrier, E. Euvrard, L. Nicod et al., “Odontoblastic differentiation of dental pulp stem cells from healthy and carious teeth on an original PCL-based 3D scaffold,” International Endodontic Journal, 2017.
- F. Wei, T. Song, G. Ding et al., “Functional tooth restoration by allogeneic mesenchymal stem cell-based bio-root regeneration in swine,” Stem Cells and Development, vol. 22, no. 12, pp. 1752–1762, 2013.
- L. E. Bertassoni, M. Cecconi, V. Manoharan et al., “Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs,” Lab on a Chip, vol. 14, no. 13, pp. 2202–2211, 2014.
- J. S. Miller, K. R. Stevens, M. T. Yang et al., “Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues,” Nature Materials, vol. 11, no. 9, pp. 768–774, 2012.
- S. Gronthos, M. Mankani, J. Brahim, P. G. Robey, and S. Shi, “Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13625–13630, 2000.
- W. Zhang, X. F. Walboomers, G. J. van Osch, J. van den Dolder, and J. A. Jansen, “Hard tissue formation in a porous HA/TCP ceramic scaffold loaded with stromal cells derived from dental pulp and bone marrow,” Tissue Engineering Part A, vol. 14, no. 2, pp. 285–294, 2008.
- Z. H. Gao, L. Hu, G. L. Liu et al., “Bio-root and implant-based restoration as a tooth replacement alternative,” Journal of Dental Research, vol. 95, no. 6, pp. 642–649, 2016.
- B. N. Cavalcanti, B. D. Zeitlin, and J. E. Nor, “A hydrogel scaffold that maintains viability and supports differentiation of dental pulp stem cells,” Dental Materials, vol. 29, no. 1, pp. 97–102, 2013.
- P. Hilkens, P. Gervois, Y. Fanton et al., “Effect of isolation methodology on stem cell properties and multilineage differentiation potential of human dental pulp stem cells,” Cell and Tissue Research, vol. 353, no. 1, pp. 65–78, 2013.
- L. Lin, K. L. Chow, and Y. Leng, “Study of hydroxyapatite osteoinductivity with an osteogenic differentiation of mesenchymal stem cells,” Journal of Biomedical Materials Research. Part A, vol. 89, no. 2, pp. 326–335, 2009.
- S. E. Lobo, R. Glickman, W. N. da Silva, T. L. Arinzeh, and I. Kerkis, “Response of stem cells from different origins to biphasic calcium phosphate bioceramics,” Cell and Tissue Research, vol. 361, no. 2, pp. 477–495, 2015.
- R. Zhang, P. R. Cooper, G. Smith, J. E. Nör, and A. J. Smith, “Angiogenic activity of dentin matrix components,” Journal of Endodontia, vol. 37, no. 1, pp. 26–30, 2011.
- Y. Bai, P. Li, G. Yin et al., “BMP-2, VEGF and bFGF synergistically promote the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells,” Biotechnology Letters, vol. 35, no. 3, pp. 301–308, 2013.
- A. D. Berendsen and B. R. Olsen, “How vascular endothelial growth factor-A (VEGF) regulates differentiation of mesenchymal stem cells,” The Journal of Histochemistry and Cytochemistry, vol. 62, no. 2, pp. 103–108, 2014.
- I. D' Alimonte, E. Nargi, F. Mastrangelo et al., “Vascular endothelial growth factor enhances in vitro proliferation and osteogenic differentiation of human dental pulp stem cells,” Journal of Biological Regulators and Homeostatic Agents, vol. 25, no. 1, pp. 57–69, 2011.
- W. Zhang, W. Liu, J. Ling et al., “Odontogenic differentiation of vascular endothelial growth factor-transfected human dental pulp stem cells in vitro,” Molecular Medicine Reports, vol. 10, no. 4, pp. 1899–1906, 2014.
- A. I. Hoch, B. Y. Binder, D. C. Genetos, and J. K. Leach, “Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells,” PLoS One, vol. 7, no. 4, article e35579, 2012.
- H. Wu, N. Kang, Q. Wang et al., “The dose-effect relationship between the seeding quantity of human marrow mesenchymal stem cells and in vivo tissue-engineered bone yield,” Cell Transplantation, vol. 24, no. 10, pp. 1957–1968, 2015.
- R. Xue, J. Y. Li, Y. Yeh, L. Yang, and S. Chien, “Effects of matrix elasticity and cell density on human mesenchymal stem cells differentiation,” Journal of Orthopaedic Research, vol. 31, no. 9, pp. 1360–1365, 2013.
- K. Iohara, K. Imabayashi, R. Ishizaka et al., “Complete pulp regeneration after pulpectomy by transplantation of CD105+ stem cells with stromal cell-derived factor-1,” Tissue Engineering Part A, vol. 17, no. 15-16, pp. 1911–1920, 2011.
- K. Iohara, M. Murakami, K. Nakata, and M. Nakashima, “Age-dependent decline in dental pulp regeneration after pulpectomy in dogs,” Experimental Gerontology, vol. 52, pp. 39–45, 2014.
Copyright © 2017 Petra Hilkens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.